awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28083239-07C4B546-A5C4-45A0-B085-230AA2518E3A
Q28083239-07C4B546-A5C4-45A0-B085-230AA2518E3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083239-07C4B546-A5C4-45A0-B085-230AA2518E3A
Re-Treatment with EGFR-TKIs in NSCLC Patients Who Developed Acquired Resistance
P2860
Q28083239-07C4B546-A5C4-45A0-B085-230AA2518E3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083239-07C4B546-A5C4-45A0-B085-230AA2518E3A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
913ecc6050b57da4d6c5478bde6c24136612b6c4
P2860
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.